strontium has been researched along with Hormone-Dependent Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delpassand, ES; Logothetis, CJ; Millikan, RE; Pagliaro, LC; Tu, SM; Williams, D | 1 |
| Baert, L; Brady, LW; Goethuys, H; Lieskovsky, G; Petrovich, Z; Van Poppel, H | 1 |
1 review(s) available for strontium and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Treatment of metastatic carcinoma of the prostate.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Male; Medical Oncology; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Strontium | 1997 |
1 trial(s) available for strontium and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases.
Topics: Aged; Bone Neoplasms; Carcinoma; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Humans; Injections, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation-Sensitizing Agents; Strontium; Strontium Radioisotopes; Testosterone | 2003 |